USD 131.31
(-1.03%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 3.84 USD | 88.52% |
2022 | 2.09 USD | 2593.3% |
2021 | 0.08 USD | -97.02% |
2020 | 2.60 USD | 142.99% |
2019 | 1.07 USD | -37.06% |
2018 | 1.70 USD | -28.27% |
2017 | 2.37 USD | -14.44% |
2016 | 2.77 USD | 24.22% |
2015 | 2.23 USD | 127.55% |
2014 | 0.98 USD | -51.96% |
2013 | 2.04 USD | -59.12% |
2012 | 4.99 USD | -31.92% |
2011 | 7.33 USD | 30.89% |
2010 | 5.60 USD | 7.9% |
2009 | 5.19 USD | 23.57% |
2008 | 4.20 USD | 12.3% |
2007 | 3.74 USD | -3.11% |
2006 | 3.86 USD | 32.65% |
2005 | 2.91 USD | -98.67% |
2004 | 218.00 USD | 22.47% |
2003 | 178.00 USD | 10753.66% |
2002 | 1.64 USD | -0.61% |
2001 | 1.65 USD | 15.38% |
2000 | 1.43 USD | 123.44% |
1999 | 0.64 USD | -56.46% |
1998 | 1.47 USD | 15.75% |
1997 | 1.27 USD | 9.48% |
1996 | 1.16 USD | 110.91% |
1995 | 0.55 USD | -24.66% |
1994 | 0.73 USD | -2.67% |
1993 | 0.75 USD | 341.18% |
1992 | 0.17 USD | -81.11% |
1991 | 0.90 USD | 50.0% |
1990 | 0.60 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | 1.25 USD | -11.43% |
2024 Q1 | 1.40 USD | 118.75% |
2023 Q1 | 1.18 USD | 96.67% |
2023 Q2 | 1.19 USD | 0.85% |
2023 Q4 | 0.64 USD | -24.71% |
2023 Q3 | 0.85 USD | -28.57% |
2023 FY | - USD | 88.52% |
2022 FY | - USD | 2593.3% |
2022 Q2 | 0.23 USD | -8.0% |
2022 Q1 | 0.25 USD | 213.64% |
2022 Q3 | 1.06 USD | 360.87% |
2022 Q4 | 0.60 USD | -43.4% |
2021 Q1 | 1.19 USD | 52.56% |
2021 Q2 | 0.42 USD | -64.71% |
2021 Q3 | -1.10 USD | -361.9% |
2021 FY | - USD | -97.02% |
2021 Q4 | -0.22 USD | 80.0% |
2020 FY | - USD | 142.99% |
2020 Q3 | 0.49 USD | -15.52% |
2020 Q4 | 0.78 USD | 59.18% |
2020 Q2 | 0.58 USD | -1.69% |
2020 Q1 | 0.59 USD | 145.83% |
2019 Q4 | 0.24 USD | 4.35% |
2019 FY | - USD | -37.06% |
2019 Q2 | 0.09 USD | -80.85% |
2019 Q3 | 0.23 USD | 155.56% |
2019 Q1 | 0.47 USD | -42.68% |
2018 Q2 | 0.27 USD | 0.0% |
2018 FY | - USD | -28.27% |
2018 Q1 | 0.27 USD | -73.79% |
2018 Q3 | 0.34 USD | 25.93% |
2018 Q4 | 0.82 USD | 141.18% |
2017 Q3 | 0.54 USD | 42.11% |
2017 FY | - USD | -14.44% |
2017 Q1 | 0.42 USD | -71.23% |
2017 Q2 | 0.38 USD | -9.52% |
2017 Q4 | 1.03 USD | 90.74% |
2016 Q3 | 0.80 USD | 33433.33% |
2016 Q2 | -0.00 USD | -100.47% |
2016 Q1 | 0.51 USD | -19.05% |
2016 FY | - USD | 24.22% |
2016 Q4 | 1.46 USD | 82.5% |
2015 Q2 | 0.55 USD | 25.0% |
2015 Q3 | 0.61 USD | 10.91% |
2015 FY | - USD | 127.55% |
2015 Q4 | 0.63 USD | 3.28% |
2015 Q1 | 0.44 USD | 276.0% |
2014 Q3 | 0.20 USD | -68.25% |
2014 FY | - USD | -51.96% |
2014 Q1 | 0.40 USD | 195.24% |
2014 Q2 | 0.63 USD | 57.5% |
2014 Q4 | -0.25 USD | -225.0% |
2013 Q1 | 0.81 USD | -33.61% |
2013 FY | - USD | -59.12% |
2013 Q4 | -0.42 USD | -142.42% |
2013 Q3 | 0.99 USD | 50.0% |
2013 Q2 | 0.66 USD | -18.52% |
2012 FY | - USD | -31.92% |
2012 Q1 | 1.28 USD | 10.34% |
2012 Q3 | 1.21 USD | -3.97% |
2012 Q4 | 1.22 USD | 0.83% |
2012 Q2 | 1.26 USD | -1.56% |
2011 Q2 | 1.53 USD | -26.44% |
2011 Q1 | 2.08 USD | 0.0% |
2011 Q3 | 2.56 USD | 67.32% |
2011 Q4 | 1.16 USD | -54.69% |
2011 FY | - USD | 30.89% |
2010 Q1 | 1.91 USD | 0.0% |
2010 Q3 | 1.08 USD | -26.03% |
2010 FY | - USD | 7.9% |
2010 Q4 | - USD | -100.0% |
2010 Q2 | 1.46 USD | -23.56% |
2009 Q2 | 1.18 USD | -20.27% |
2009 FY | - USD | 23.57% |
2009 Q3 | 1.46 USD | 23.73% |
2009 Q1 | 1.48 USD | 0.0% |
2009 Q4 | - USD | -100.0% |
2008 Q3 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 FY | - USD | 12.3% |
2008 Q2 | - USD | -100.0% |
2008 Q1 | 1.03 USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q1 | 1.02 USD | 0.0% |
2007 Q2 | - USD | -100.0% |
2007 FY | - USD | -3.11% |
2007 Q3 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q2 | - USD | -100.0% |
2006 FY | - USD | 32.65% |
2006 Q1 | 0.90 USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q2 | - USD | -100.0% |
2005 FY | - USD | -98.67% |
2005 Q1 | 63.00 USD | 0.0% |
2004 Q4 | - USD | -100.0% |
2004 Q2 | 0.48 USD | -98.98% |
2004 Q1 | 47.00 USD | 0.0% |
2004 FY | - USD | 22.47% |
2004 Q3 | 0.68 USD | 41.67% |
2003 Q1 | 0.54 USD | 0.0% |
2003 FY | - USD | 10753.66% |
2003 Q4 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q2 | - USD | -100.0% |
2002 Q1 | 0.55 USD | 0.0% |
2002 Q2 | 0.45 USD | -18.18% |
2002 Q3 | - USD | -100.0% |
2002 Q4 | - USD | 0.0% |
2002 FY | - USD | -0.61% |
2001 FY | - USD | 15.38% |
2001 Q1 | 0.44 USD | 0.0% |
2001 Q3 | 0.42 USD | 7.69% |
2001 Q2 | 0.39 USD | -11.36% |
2001 Q4 | - USD | -100.0% |
2000 Q2 | - USD | -100.0% |
2000 FY | - USD | 123.44% |
2000 Q3 | - USD | 0.0% |
2000 Q4 | - USD | 0.0% |
2000 Q1 | 0.38 USD | 0.0% |
1999 Q4 | - USD | -100.0% |
1999 Q3 | 0.27 USD | 12.5% |
1999 Q2 | 0.24 USD | 0.0% |
1999 FY | - USD | -56.46% |
1999 Q1 | 0.24 USD | 0.0% |
1998 Q3 | 0.25 USD | -39.02% |
1998 FY | - USD | 15.75% |
1998 Q1 | 0.39 USD | 0.0% |
1998 Q2 | 0.41 USD | 5.13% |
1998 Q4 | - USD | -100.0% |
1997 Q4 | - USD | -100.0% |
1997 FY | - USD | 9.48% |
1997 Q3 | 0.93 USD | 138.46% |
1997 Q2 | 0.39 USD | 0.0% |
1997 Q1 | 0.39 USD | 0.0% |
1996 Q3 | 0.25 USD | -24.24% |
1996 FY | - USD | 110.91% |
1996 Q2 | 0.33 USD | 0.0% |
1996 Q1 | 0.33 USD | 0.0% |
1996 Q4 | - USD | -100.0% |
1995 Q3 | 0.24 USD | -17.24% |
1995 Q2 | 0.29 USD | 3.57% |
1995 FY | - USD | -24.66% |
1995 Q4 | - USD | -100.0% |
1995 Q1 | 0.28 USD | 0.0% |
1994 Q2 | 0.25 USD | 92.31% |
1994 Q4 | - USD | -100.0% |
1994 Q1 | 0.13 USD | 0.0% |
1994 Q3 | 0.22 USD | -12.0% |
1994 FY | - USD | -2.67% |
1993 Q1 | 0.25 USD | 0.0% |
1993 Q3 | 0.13 USD | -48.0% |
1993 Q4 | - USD | -100.0% |
1993 FY | - USD | 341.18% |
1993 Q2 | 0.25 USD | 0.0% |
1992 FY | - USD | -81.11% |
1991 FY | - USD | 50.0% |
1990 FY | - USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Bristol-Myers Squibb Company PFD CONV 2 | 3.88 USD | 1.031% |
CSPC Pharmaceutical Group Limited | 0.07 USD | -5385.714% |
Clarus Therapeutics Holdings, Inc. | -8.04 USD | 147.761% |
Novartis AG | 7.63 USD | 49.672% |
PT Kalbe Farma Tbk. | 0.00 USD | -98361.538% |